There isn't going to be a 'one size fits all' Covid treatment: Analyst

CNBC's "Power Lunch" team breaks down how the vaccine stocks are trading and what investors should know about the race to therapies with Alethia Young, analyst at Cantor Fitzgerald.
02:57
Tue, Oct 27 20203:18 PM EDT